Lewin N, Aman P, Mellstedt H, Carenfelt C, Klein G, Klein E
Department of Tumor Biology, Karolinska Institute, Stockholm, Sweden.
Anticancer Res. 1990 Sep-Oct;10(5A):1213-6.
Three patients with Hodgkin's disease (HD) and 7 patients with non Hodgkin lymphoma (NHL) who had high antibody titers against Epstein Barr virus (EBV) capsid antigens (VCA) were studied for the occurrence of EBV carrying B cells in the blood. The outgrowth of lymphoblastoid cell lines (LCLs) in their blood lymphocyte culture was tested in the presence of Cyclosporin A, which abrogates the growth inhibitory effect of T cells. Transformation occurred in the cultures of 4/10 patients and 4/10 age matched healthy individuals. The frequency of transformation in wells seeded with identical cells number from these 4 individuals in each group did not differ. Thus the lymphoma patients with high anti VCA titers did not show elevated level of EBV carrying B cells in the blood.
对3例霍奇金病(HD)患者和7例非霍奇金淋巴瘤(NHL)患者进行了研究,这些患者针对爱泼斯坦-巴尔病毒(EBV)衣壳抗原(VCA)具有高抗体滴度,以检测血液中携带EBV的B细胞的发生情况。在存在环孢菌素A的情况下测试了他们血液淋巴细胞培养物中淋巴母细胞样细胞系(LCL)的生长,环孢菌素A可消除T细胞的生长抑制作用。4/10例患者和4/10例年龄匹配的健康个体的培养物中发生了转化。每组中这4个人接种相同细胞数的孔中转化频率没有差异。因此,抗VCA滴度高的淋巴瘤患者血液中携带EBV的B细胞水平并未升高。